{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:50:32Z","timestamp":1781650232461,"version":"3.54.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T00:00:00Z","timestamp":1178064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-37","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T17:01:25Z","timestamp":1178211685000},"source":"Crossref","is-referenced-by-count":76,"title":["Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy"],"prefix":"10.1186","volume":"7","author":[{"given":"Christina M","family":"Marra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Imrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,2]]},"reference":[{"key":"480_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2334-5-98","volume":"5","author":"SS Spudich","year":"2005","unstructured":"Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW: Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005, 5: 98-10.1186\/1471-2334-5-98.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"480_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol. 1997, 42 (5): 679-688. 10.1002\/ana.410420503.","journal-title":"Ann Neurol"},{"issue":"9","key":"480_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archneur.1988.00520330032007","volume":"45","author":"DW Marshall","year":"1988","unstructured":"Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN: Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol. 1988, 45 (9): 954-958.","journal-title":"Arch Neurol"},{"issue":"4","key":"480_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","volume":"21","author":"M Gisslen","year":"1999","unstructured":"Gisslen M, Fuchs D, Svennerholm B, Hagberg L: Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr. 1999, 21 (4): 271-276.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"480_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/517379","volume":"177","author":"L Morris","year":"1998","unstructured":"Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, Saffer D, Koornhof H, Martin DJ: High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J Infect Dis. 1998, 177 (2): 473-476.","journal-title":"J Infect Dis"},{"issue":"3","key":"480_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/00042560-199803010-00005","volume":"17","author":"C Martin","year":"1998","unstructured":"Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A: Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 17 (3): 214-219.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"12","key":"480_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/508750","volume":"194","author":"S Spudich","year":"2006","unstructured":"Spudich S, Lollo N, Liegler T, Deeks SG, Price RW: Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis. 2006, 194 (12): 1686-1696. 10.1086\/508750.","journal-title":"J Infect Dis"},{"issue":"3","key":"480_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/09540120050042891","volume":"12","author":"MA Chesney","year":"2000","unstructured":"Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) [In Process Citation]. AIDS Care. 2000, 12 (3): 255-266. 10.1080\/09540120050042891.","journal-title":"AIDS Care"},{"issue":"3","key":"480_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.59.3.342","volume":"59","author":"A De Luca","year":"2002","unstructured":"De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L: Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology. 2002, 59 (3): 342-347.","journal-title":"Neurology"},{"issue":"1","key":"480_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.51.1.221","volume":"51","author":"BA Navia","year":"1998","unstructured":"Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA: A phase I\/II trial of nimodipine for HIV-related neurologic complications. Neurology. 1998, 51 (1): 221-228.","journal-title":"Neurology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:48:40Z","timestamp":1548218920000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-37","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,2]]},"article-number":"37"}}